Affiance Medi Tech Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 13-12-2024
- Paid Up Capital ₹ 5.40 M
as on 13-12-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 4.80 Cr
as on 13-12-2024
- Satisfied Charges ₹ 1.80 Cr
as on 13-12-2024
- Revenue -53.52%
(FY 2018)
- Profit -4956.35%
(FY 2018)
- Ebitda -142.23%
(FY 2018)
- Net Worth -71.54%
(FY 2018)
- Total Assets 0.58%
(FY 2018)
About Affiance Medi Tech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 5.40 M.
The company currently has active open charges totaling ₹4.80 Cr. The company has closed loans amounting to ₹1.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yashodhan Deshpande and Manasi Deshpande serve as directors at the Company.
- CIN/LLPIN
U93090MH2009PTC190979
- Company No.
190979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2009
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Affiance Medi Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manasi Deshpande  | Director | 24-Feb-2017 | Current |
| Yashodhan Deshpande | Director | 17-Mar-2009 | Current |
Financial Performance of Affiance Medi Tech.
Affiance Medi Tech Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 53.52% decrease. The company also saw a substantial fall in profitability, with a 4956.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 71.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Affiance Medi Tech?
In 2018, Affiance Medi Tech had a promoter holding of 91.94% and a public holding of 8.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 26 Nov 2011 | ₹4.80 Cr | Open |
State Bank Of India Creation Date: 05 Jun 2010 | ₹1.30 Cr | Satisfied |
Union Bank Of India Creation Date: 13 Aug 2009 | ₹5.00 M | Satisfied |
How Many Employees Work at Affiance Medi Tech?
Unlock and access historical data on people associated with Affiance Medi Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Affiance Medi Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affiance Medi Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
